Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anita Chudecka-Glaz"'
Autor:
Bradley J. Monk, Christine Parkinson, Myong Cheol Lim, David M. O'Malley, Ana Oaknin, Michelle K. Wilson, Robert L. Coleman, Domenica Lorusso, Paul Bessette, Sharad Ghamande, Athina Christopoulou, Diane Provencher, Emily Prendergast, Fuat Demirkiran, Olga Mikheeva, Oladapo Yeku, Anita Chudecka-Glaz, Michael Schenker, Ramey D. Littell, Tamar Safra, Hung-Hsueh Chou, Mark A. Morgan, Vít Drochýtek, Joyce N. Barlin, Toon Van Gorp, Fred Ueland, Gabriel Lindahl, Charles Anderson, Dearbhaile C. Collins, Kathleen Moore, Frederik Marme, Shannon N. Westin, Iain A. McNeish, Danny Shih, Kevin K. Lin, Sandra Goble, Stephanie Hume, Keiichi Fujiwara, Rebecca S. Kristeleit
Publikováno v:
Scientia
PURPOSE ATHENA (ClinicalTrials.gov identifier: NCT03522246 ) was designed to evaluate rucaparib first-line maintenance treatment in a broad patient population, including those without BRCA1 or BRCA2 (BRCA) mutations or other evidence of homologous re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312a6e609ec98f3f3c5b48462663544d
https://hdl.handle.net/11351/8726
https://hdl.handle.net/11351/8726
Autor:
Jacek J. Sznurkowski, Janusz Rys, Artur Kowalik, Agnieszka Zolciak-Siwinska, Lubomir Bodnar, Anita Chudecka-Glaz, Pawel Blecharz, Aleksandra Zielinska, Andrzej Marszalek, Mariusz Bidzinski, Wlodzimierz Sawicki
Publikováno v:
Journal of Clinical Medicine. 12:1480
Background: Due to the increasing amount of published data suggesting that endometrial carcinoma is a heterogenic entity with possible different treatment sequences and post-treatment follow-up, the Polish Society of Gynecological Oncology (PSGO) has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab7432c41b8cb2abcb1ba776b1ce496c
https://doi.org/10.3390/jcm12041480
https://doi.org/10.3390/jcm12041480
Autor:
Aneta, Cymbaluk-Ploska, Anita, Chudecka-Glaz, Anna, Surowiec, Ewa, Pius-Sadowska, Boguslaw, Machalinski, Janusz, Menkiszak
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 17(5)
Ovarian cancer is a highly malignant neoplasm with high mortality rates. Research to identify markers facilitating early detection has been pursued for many years. Currently, diagnosis is based on the CA 125 and HE4 markers, as well as the ROMA algor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d01e122225c58ea8545cd70974d6798
https://pubmed.ncbi.nlm.nih.gov/27268637
https://pubmed.ncbi.nlm.nih.gov/27268637
Autor:
Anna Jagodzińska, Anita Chudecka-Głaz, Kaja Michalczyk, Ewa Pius-Sadowska, Sylwia Wieder-Huszla, Anna Jurczak, Bogusław Machaliński
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 399 (2023)
Endometrial cancer is becoming an increasing problem. Taking into account its pathomechanisms, we aimed to investigate whether FGF 21, an important metabolism regulator, could be used as a biomarker for endometrial cancer. The study included 233 pati
Externí odkaz:
https://doaj.org/article/be5caab9b2d14cabb610de8c1115357b
Autor:
Anita Chudecka-Głaz, Aleksandra Strojna, Kaja Michalczyk, Sylwia Wieder-Huszla, Krzysztof Safranow, Edyta Skwirczyńska, Anna Jurczak
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 452 (2023)
HE4 is a commonly used tumor marker for ovarian cancer (OC) diagnosis. In our study, we aimed to assess its use in the diagnosis of subsequent OC recurrences and to evaluate its changes during recurrence diagnosis and the subsequent lines of chemothe
Externí odkaz:
https://doaj.org/article/59df127cc98c41ce8a7168b1c3d3cb2e
Autor:
Janusz Menkiszak, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Aleksander Celewicz, Zbigniew Kojs, Mariusz Szajda, Maria Świniarska, Ryszard Bedner, Anna Jurczak, Marta Celewicz, Monika Cieszyńska, Jan Lubiński, Jacek Gronwald
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-5 (2019)
Abstract Background Since more than two decades Risk-reducing salpingo-oophorectomy (RRSO) is recommended and widely accepted by BRCA1/2 carriers as a method reducing ovarian cancer risk and improving survival rate. After RRSO, there remains a risk o
Externí odkaz:
https://doaj.org/article/50ca9ca7ca9141169059d841e82b1b13
Autor:
Aneta Cymbaluk-Płoska, Anita Chudecka-Głaz, Ewa Pius-Sadowska, Bogusław Machaliński, Janusz Menkiszak, Agnieszka Sompolska-Rzechuła
Publikováno v:
Journal of Ovarian Research, Vol 11, Iss 1, Pp 1-9 (2018)
Abstract Background MMP and TIMP play an important role in the degradation of extracellular matrix components which are essential for tumor growth, invasion and metastasis. Aim of this research was to assess MMP3 and TIMP3 as prognostic factors among
Externí odkaz:
https://doaj.org/article/4d006c066d4a45ab8b618c79c2b490fc
Autor:
Aneta Cymbaluk-Płoska, Karolina Chudecka, Anita Chudecka-Głaz, Katarzyna Piotrowska, Sebastian Kwiatkowski, Maciej Tarnowski
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 1026 (2021)
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our study, we compare a number of proteins from different effector pathways to assess their usefulness in the diagnosis of ovarian cancer. The tissue expression of th
Externí odkaz:
https://doaj.org/article/756e8cdfadf64938b2c044a7e163dd49
Autor:
Tomasz Nikodemski, Agnieszka Biskup, Aleksandra Taszarek, Małgorzata Albin, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Janusz Menkiszak
Publikováno v:
Contemporary Oncology, Vol 21, Iss 3, Pp 240-243 (2017)
Aim of the study : An ERAS protocol provides the latest perioperative care principles, whose primary aim is to reduce complication rates, and therefore mortality. The aim of this study is to establish the progress of the ERAS pathway implementation i
Externí odkaz:
https://doaj.org/article/acb2e90f5b6f46db8bc9ea35e2fd1888
Autor:
Aneta Cymbaluk-Płoska, Paula Gargulińska, Michał Bulsa, Sebastian Kwiatkowski, Anita Chudecka-Głaz, Kaja Michalczyk
Publikováno v:
Diagnostics, Vol 11, Iss 4, p 626 (2021)
The aim of our research was to determine the use of CA125 and HE4 as prognostic factors in patients with different clinical staging of endometrial cancer. Sixty-two patients with advanced endometrial cancer and 287 patients with early stage endometri
Externí odkaz:
https://doaj.org/article/3f0fd74e8b794f76bcc77faaf9b545f0